Latest News by Industry
BOTHELL, Wash. (AP) — BOTHELL, Wash. (AP) — Seattle Genetics Inc. (SGEN) on Thursday reported a loss of $174.7 million in its first quarter.
On a per-share basis, the Bothell, Washington-based company said it had a loss of 93 cents.
The results missed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of 82 cents per share.
The biotechnology company posted revenue of $519.7 million in the period, also missing Street forecasts. Ten analysts surveyed by Zacks expected $520.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a SGEN">Zacks stock report on SGEN at https://www.zacks.com/ap/SGEN